Loading…

A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions

•The bivalent vaccine elicited immune responses against PCV2 and M. hyopneumoniae.•Pigs vaccinated with the bivalent vaccine decreased mortality rate of 13.4%.•Pigs vaccinated with the bivalent vaccine increased market weight of 6.2kg/pig. The efficacy of the new single-dose bivalent vaccine of porc...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary microbiology 2016-01, Vol.182, p.178-186
Main Authors: Jeong, Jiwoon, Park, Changhoon, Choi, Kyuhyung, Chae, Chanhee
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The bivalent vaccine elicited immune responses against PCV2 and M. hyopneumoniae.•Pigs vaccinated with the bivalent vaccine decreased mortality rate of 13.4%.•Pigs vaccinated with the bivalent vaccine increased market weight of 6.2kg/pig. The efficacy of the new single-dose bivalent vaccine of porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae was evaluated under field conditions for registration as recommended by the Republic of Korea’s Animal, Plant & Fisheries Quarantine & Inspection Agency. Three farms were selected based on their history of co-infection with PCV2 and M. hyopneumoniae. On each farm, a total of 80 3-week-old pigs were randomly allocated to one of two treatment groups: (i) vaccinated (n=40) and (ii) unvaccinated (n=40) animals at 3 weeks of age. Protection by the bivalent vaccine helped increase the market weight by 6.2kg/pig (106.2kg in vaccinated group vs. 100kg in unvaccinated group; P
ISSN:0378-1135
1873-2542
DOI:10.1016/j.vetmic.2015.11.023